Self-injection and Self-management

Completed · Not applicable

Conditions studied: Food Allergy

In brief

The purpose of the present study is to determine if asking adolescent patients (ages 13-17) to self-inject an empty syringe into their thigh during routine clinic visits results in increased reported comfort with self-injection, reduced anxiety regarding self-injection and food allergy management for both patient and caregiver(s), and in greater perceived likelihood of epinephrine self-injection, in the event of an emergency.

Key facts

Study ID

NCT02417493

Run by

Icahn School of Medicine at Mount Sinai

People needed

60

Starts

2015-03-01

Expected to finish

2016-06-01

Last updated by the study team

2016-07-01

Who can join

Age: 13 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients seen in the outpatient clinic and their caretakers (no inpatients).
• Patients must have been diagnosed with food allergy and previously prescribed self-injectable epinephrine.
• Patients between the ages of 13-17 years old.
• Parent consent and child assent.

You may not qualify if…

• Patients and caregiver(s) who have been diagnosed with cognitive barriers that prevent them from understanding the study, as determined by either: a previously diagnosed mental retardation or inability to repeat the study protocol at the time of consent.

Where it is running

• Jaffe Food Allergy Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.